Umeclidinium + Vilanterol

Category: Lungs (Pulmonary)

Umeclidinium + Vilanterol Overview

Vilanterol (INN, USAN) is an ultra-long-acting β2 adrenoreceptor agonist (ultra-LABA), which was approved in May 2013 in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD).[1] Vilanterol is available in following combinations: with inhaled corticosteroid fluticasone furoate—fluticasone furoate/vilanterol (trade names Breo Ellipta (U.S.), Relvar Ellipta (EU, RU, JPN)) wit...

Read more Umeclidinium + Vilanterol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Umeclidinium + Vilanterol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Umeclidinium + Vilanterol
  • Powder: 0.0625mg/inh + 0.025mg/inh, 62.5mcg + 25mcg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (7 results)

Related Umeclidinium + Vilanterol Topics:

vilanterol. Is anoro available in east africa.
is anoiro ellipta available in Africa. I want to know if anoro ellipta is being marketed in africa...

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 October 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA